Call us now

08071779111

15mg Upadacitinib Extended Relelease Tablets

Send Inquiry

Request To Call Back

15mg Upadacitinib Extended Relelease Tablets

Name: 15mg Upadacitinib Extended Relelease Tablets
Brand: GLOBMED INDIA

Get a Price/Quote

MOQ : 5 Strips

15mg Upadacitinib Extended Relelease Tablets Specification

Salt Composition
Upadacitinib

Life Span
Refer packaging for expiry date

Indication
Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis (as per physicians direction)

Brand Name
Upadoz 15

Origin of Medicine
India

Packaging Type
Bottle and carton

Pacakaging (Quantity Per Box)
30 tablets

Dosage Form
Extended-release tablet

Drug Type
Prescription medicine

Ingredients
Upadacitinib 15 mg

Physical Form
Tablet

Function
Janus kinase (JAK) inhibitor, reduces inflammation and immune response

Recommended For
Adults with moderate to severe rheumatoid arthritis and related inflammatory conditions

Dosage
As directed by physician, typically 15 mg once daily

Dosage Guidelines
Take exactly as prescribed, swallow whole, do not crush or chew

Quantity
30 tablets per bottle

Storage Instructions
Store below 30C, keep away from light and moisture

Therapeutic Class
Immunomodulator

Warning
Follow all physician advice, arrange periodic laboratory tests as recommended

Schedule
Schedule H (Prescription required)

Administration Route
Oral

Tablet Color
Off-white/White

Marketed By
MSN Laboratories

Maximum Retail Price (MRP)
Refer product packaging

Caution
Not for use in pregnancy and lactation unless directed by a doctor

Patient Type
Not for use in children without medical advice

Intake Timing
Can be taken with or without food

15mg Upadacitinib Extended Relelease Tablets Trade Information

Minimum Order Quantity
5 Strips

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Strips Per Month

Delivery Time
2-5 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

15mg Upadacitinib Extended Relelease Tablets About

Discover Upadoz 15-Upadacitinib 15mg Extended Release Tablets, brought to you by the illustrious MSN Laboratories in India. Engineered for adults, this immunomodulator offers an unprecedented leap in managing moderate to severe rheumatoid arthritis and related inflammatory disorders. Personalise your treatment-these unbeatable extended-release tablets ensure all-day relief and optimal control of your condition. With the latest in JAK inhibitor technology, Upadoz 15 reduces inflammation and immune response, empowering better outcomes. Order today-prescription required, and always follow your physician's guidance for safe, effective use.

Key Features and Recommended Application

Upadoz 15 Tablets deliver extended-release Upadacitinib-ideal for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, as prescribed. Each off-white/white tablet contains 15 mg of the active ingredient to ensure steady, effective relief. Suitable for oral administration, they may be taken with or without food. Designed for use under close physician supervision, these tablets require strict adherence to prescribed dosages for optimal therapeutic benefits.

Shipping Standards and Supply Certifications

Upadoz 15 Tablets are dispatched from India through renowned FOB ports to guarantee swift worldwide distribution. Our secure shipping protocols ensure the product's integrity, maintaining quality throughout transportation. We maintain robust supply ability to meet global demand efficiently. All batches are manufactured to the highest standards, supported by acclaimed certifications, ensuring reliability and safety in every shipment.

FAQ's of 15mg Upadacitinib Extended Relelease Tablets:

Q: How should Upadoz 15 Tablets be used for best results?

A: Take one tablet (15 mg) orally once daily, exactly as prescribed by your physician. Swallow whole, without crushing or chewing, and adhere to all other medical advice for optimal benefit.

Q: What conditions are Upadacitinib Extended Release Tablets indicated for?

A: Upadoz 15 is recommended for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis, according to physician's directions.

Q: When should I monitor for possible side effects or arrange tests?

A: Periodic laboratory tests, as advised by your doctor, are important during Upadacitinib therapy. Always monitor for side effects and immediately report any unusual symptoms.

Q: Where should I store these tablets to maintain efficacy?

A: Store Upadoz 15 Tablets below 30C, away from direct light and moisture, to preserve their effectiveness and shelf life.

Q: What are the key benefits of Upadacitinib as an immunomodulator?

A: Upadacitinib, a Janus kinase (JAK) inhibitor, offers unprecedented reduction in inflammation and helps regulate immune response, delivering reliable relief from chronic inflammatory conditions.

Tell us about your requirement